Femselect INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$309Kgeneral payments (2019-2025)
$1,925research payments (2019-2025)
389clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $26K
2020 $66K
2021 $24K
2022 $25K
2023 $32K
2024 $65K
2025 $70K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $215K
Urology $37K
Obstetrics & Gynecology $29K
Urogynecology and Reconstructive Pelvic Surgery (Urology) $13K
Gynecology $9,197
Family Medicine $682

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Vincent Lucente Allentown, PA Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $162,954.78
Grace Biggs Derby, CT Urology $21,465.45
Seyed Shobeiri Falls Church, VA Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $12,974.09
Anthony Gaddi Gilbert, AZ Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $9,828.74
Sandy Nosseir Marlton, NJ Urogynecology and Reconstructive Pelvic Surgery (Urology) $7,500.88
Dara Shalom Great Neck, NY Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $7,499.24
Andrea Pezzella West Columbia, SC Gynecology $7,109.30
Ty Erickson Idaho Falls, ID Obstetrics & Gynecology $6,000.00
Daniel Jaffee Phoenix, AZ Urology $4,939.31
Sherry Thomas Westlake Village, CA Obstetrics & Gynecology $4,004.67

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.